Nitric Oxide Reverses Aspirin Antagonism of t-PA Thrombolysis in a Rabbit Model of Thromboembolic Stroke

By Bednar M.M.   Gross C.E.   Howard D.B.   Russell S.R.   Thomas G.R.  

Experimental Neurology, Vol. 146, Iss. 2, 1997-08 ,pp. : 513-517

Elsevier

Access to resources Recommend Favorite

THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models

By Krakovsky M   Polianski V   Nimrod A   Higazi A   Leker R R   Lamensdorf I  

Neurological Research, Vol. 33, Iss. 9, 2011-11 ,pp. : 983-990

Maney Publishing

Access to resources Recommend Favorite

The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer’s disease

By Melchor Jerry   Pawlak Robert   Chen Zulin   Strickland Sidney  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 287-289

Humana Press, Inc

Access to resources Recommend Favorite

A simple clinical and MRI scale to predict good outcome in t-PA patients

By Kimura Kazumi   Sakamoto Yuki   Iguchi Yasuyuki   Shibazaki Kensaku   Watanabe Masao   Aoki Junya   Inoue Takeshi   Uemura Junichi  

Neurological Research, Vol. 33, Iss. 10, 2011-12 ,pp. : 1038-1043

Maney Publishing

Access to resources Recommend Favorite

Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain

By Zhang Wenri   Sato Keiko   Hayashi Takeshi   Omori Nobuhiko   Nagano Isao   Kato Shinsuke   Horiuchi Seikoh   Abe Koji  

Neurological Research, Vol. 26, Iss. 3, 2004-04 ,pp. : 342-348

Maney Publishing

Access to resources Recommend Favorite